Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Vorapaxar on Thrombin Generation and Coagulability
NCT03207451Phase 4Completed
- Sponsor
- Inova Health System
- Start
- Jan 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vorapaxar in coronary artery disease (CAD), peripheral vascular disease (PVD), myocardial infarction (MI), sponsored by Inova Health System. Started Jan 2016; status: completed.
02
Drugs
vorapaxar
03
Conditions
coronary artery disease (CAD)peripheral vascular disease (PVD)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03207451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03207451.